NDC 0085-1168

INTRON A

Interferon Alfa-2b

INTRON A is a Intramuscular; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Interferon Alfa-2b.

Product ID0085-1168_117415fa-9a82-40ff-97c2-df0b6ed005a2
NDC0085-1168
Product TypeHuman Prescription Drug
Proprietary NameINTRON A
Generic NameInterferon Alfa-2b
Dosage FormInjection, Solution
Route of AdministrationINTRAMUSCULAR; SUBCUTANEOUS
Marketing Start Date1986-06-04
Marketing CategoryBLA / BLA
Application NumberBLA103132
Labeler NameMerck Sharp & Dohme Corp.
Substance NameINTERFERON ALFA-2B
Active Ingredient Strength12 ug/.5mL
Pharm ClassesInterferon-alpha [CS],Interferon alpha [EPC],Interferon-alpha [CS]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 0085-1168-01

1 VIAL, MULTI-DOSE in 1 CARTON (0085-1168-01) > 3.8 mL in 1 VIAL, MULTI-DOSE
Marketing Start Date1986-06-04
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0085-1168-01 [00085116801]

INTRON A INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA103132
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1986-06-04

Drug Details

Active Ingredients

IngredientStrength
INTERFERON ALFA-2B11.6 ug/.5mL

OpenFDA Data

SPL SET ID:30789790-8317-49f9-b97b-8c5ba17b53d2
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 204445
  • 1251596
  • 1720881
  • 545289
  • 545293
  • 1720878
  • 207029
  • 1232574
  • 207035
  • 311078
  • Pharmacological Class

    • Interferon-alpha [CS]
    • Interferon alpha [EPC]
    • Interferon-alpha [CS]

    NDC Crossover Matching brand name "INTRON A" or generic name "Interferon Alfa-2b"

    NDCBrand NameGeneric Name
    0085-1133INTRON AInterferon alfa-2b
    0085-1168INTRON AInterferon alfa-2b
    0085-4350INTRON Ainterferon alfa-2b
    0085-4351INTRON Ainterferon alfa-2b
    0085-4352INTRON Ainterferon alfa-2b

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.